Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Boric acid shares a unique corner in chemical history. Its use dates back hundreds of years. Ancient people first recognized its mild antiseptic properties during the age of apothecaries. European chemists in the 1700s managed to extract and purify it from natural sources, especially volcanic regions in Italy. Over time, scientists refined its manufacturing, using borax as a precursor and shifting to large-scale processing as global industry expanded. The British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia each developed grading standards to keep purity consistent, especially as the pharmaceutical industry took off in the 20th century. Modern factories meet rigorous requirements, driven by strict oversight from regulatory bodies.
Boric acid BP EP USP pharma grade comes as a white, odorless crystal or fine powder. In pharmacies and laboratories, it often shows up on labels as hydrogen borate or orthoboric acid. Manufacturers focus on minimizing impurities, keeping heavy metals, sulfates, and chlorides below industry thresholds. This attention to detail gives medical professionals confidence in wound care, eye washes, and other sensitive uses. Packaging stresses airtight containment since the product draws moisture from air, clumping over time and making dosing unreliable for high-accuracy lab work if not handled properly. Labels reflect pharmacopoeia standards, stating batch numbers, manufacturing dates, and crucial analytical data.
Boric acid’s physical traits reflect its simple molecular structure: H3BO3. Its melting point rests around 170°C, and it slowly vaporizes under strong heat. The surface glistens with a pearly luster, but it’s soft and powdery in most pharma-grade applications. It dissolves sparingly in cold water but manages greater solubility with heat, important for lab preparations that call for accurate dosing in solution. Its pH in water leans slightly acidic, a fact that pharmacists keep in mind when formulating treatments for sensitive skin or eye membranes. In the pharmaceutical world, even small variations in particle size can affect absorption or reactivity, so manufacturers sort and mill boric acid to precise sizes before shipment.
What sets BP EP USP grades apart comes down to tests and tight restrictions. Analytical reports show exactly how much boric acid sits in a batch, often falling between 99.5% and 100.5% purity after drying. All labs check for arsenic, lead, and other common contaminants, recording results in parts per million. Sterilization is crucial for sterile products, handled in dedicated rooms with no cross-contamination. Containers usually state the manufacturing site, country of origin, and all regulatory certification logos demanded by destination countries. This transparency helps hospitals and research labs trace problems to their source, should any issues emerge during use.
Industrially, boric acid gets made by reacting borax, a naturally occurring mineral, with sulfuric or hydrochloric acid. The reaction creates boric acid, which then gets filtered, washed, and crystallized out of solution. Companies commonly employ large crystalizers and centrifuges, then dry the crystals under vacuum to guard against airborne contaminants. Rigorous washing steps reduce residual acid or salts, so the final material meets pharmacopoeial purity grades. Each batch undergoes repeated laboratory analysis before release, assuring that manufacturers catch deviations before the product reaches patients or scientists.
Boric acid reacts predictably with strong bases, producing borates—compounds widely used as flame retardants and disinfectants. It behaves like a weak Lewis acid and forms complexes with alcohols or glycols, helping scientists design precise buffer solutions for calibrating lab instruments or stabilizing sensitive preparations. Heating it above its melting point drives water off to create metaboric acid, showing up in specialty industrial formulations. Pharmaceutical technologists have studied how different grades interact with common excipients, wanting to avoid unwanted side reactions or loss of product potency over time.
People know boric acid from different names and codes: orthoboric acid, acidum boricum, hydrogen borate, and even E284 in the food industry. Pharmacies and chemical suppliers may note the CAS number 10043-35-3. For trade, it appears under brand names or as “pharma grade boric acid” in order catalogs. This mix of names crops up on import records, regulatory filings, and safety reports, making clear communication a necessity between buyers, customs, and regulators.
Health and safety have shaped every aspect of boric acid handling in pharmaceutical settings. At low concentrations, boric acid works well as an antiseptic, and for decades, doctors used it in eyewash and skin lotions. Inhaling concentrated dust, though, irritates the nose and lungs, while long-term skin contact leaves some people with dermatitis. Workers in manufacturing wear masks and gloves, especially when handling powder in bulk. Storage areas stay cool and dry, and safety data sheets hang nearby, advising on spill cleanup and first aid. Major guidelines from OSHA, REACH, and UN GHS classify it as toxic at higher doses, especially for infants or pregnant women, so good labeling and access controls matter.
Boric acid’s main claim to fame in medicine comes from its antiseptic, antifungal, and mild astringent powers. Dermatologists use it in ointments for rashes and minor burns. It helps treat fungal nail infections and gets mixed into powders for athlete’s foot. In ophthalmology, pharmaceutical boric acid finds a home in buffered eye washes and irrigation solutions, thanks to its ability to soothe without stinging. Hospital pharmacists turn it into boric acid capsules for urinary tract infections—especially when antibiotic resistance limits treatment options. Beyond human medicine, veterinary clinics apply it for similar purposes, always watching dosage to avoid toxic effects.
Researchers see boric acid as more than just an old-fashioned disinfectant. Ongoing studies include boron-based nanoparticles that deliver drugs to tumors, exploiting the element’s special affinity for some cancer cells. Pharmacologists observe how boric acid inhibits enzyme systems in microbes, which could help design new classes of antimicrobial drugs. Environmental scientists probe its trace levels in water and food, wanting to understand background exposure in the general population. In agricultural science, boric acid functions as a micro-nutrient for plants, though researchers warn about runoff affecting aquatic organisms.
Toxicologists have examined boric acid’s safety profile for decades. In low doses, adults tolerate it well, but ingestion of large quantities over time causes nausea, skin peeling, and kidney damage. Its history includes severe poisonings in infants exposed to old-fashioned medicinal powders. Regulatory bodies monitor limits closely: the European Food Safety Authority and U.S. Food and Drug Administration cap residues in certain foods, while occupational health agencies regularly update limits for inhalable dust levels. Scientists continue animal testing to pin down non-lethal dose levels and long-term reproductive effects, leading to tighter rules and labeling requirements.
Boric acid's path looks busy in the years ahead. Ongoing improvements in refining and analytical techniques promise even higher purity grades, unlocking new medical and laboratory uses. With drug resistance on the rise, boron compounds are attracting renewed interest as possible alternatives or adjuncts to antibiotics. As countries step up oversight of industrial chemicals, expect to see stricter environmental discharge rules and more data collection on health effects. Companies developing drug delivery technologies aim to harness boric acid’s chemistry in cancer therapies, slow-release implants, and even biodegradable medical devices. The challenge will be balancing its powerful biological traits with a safety record fit for a world increasingly wary of hidden risks in even the most familiar chemicals.
Boric acid, meeting BP, EP, and USP standards, plays an important role in wound care. Its mild antiseptic qualities help lower infection risks in minor burns, cuts, and skin irritations. I remember seeing boric acid powder stocked in many rural clinics, usually because it handles a range of skin issues when more advanced care isn’t available. The key is that pharmaceutical-grade boric acid includes very low impurity levels, meeting the strict rules set by pharmacopoeias. This protects patients who already have vulnerable immune systems.
Boric acid doesn’t show up on TV commercials for eye drops, but plenty of ophthalmic solutions count on it. In products like sterile eye washes or saline eye drop solutions, boric acid acts as a buffering agent. It keeps the pH where eyes feel comfortable and less prone to irritation. With safety checks set by global pharmacopeias, only highly purified boric acid avoids eye damage and allergic reactions. I saw this up close during a pharmacology rotation when a patient came in with an irritated eye, and the doctor asked for a boric acid solution right away. People sometimes overlook how much behind-the-scenes chemistry keeps common medicines gentle on the body.
Boric acid shows up in various antifungal creams and powders, especially for treating yeast infections. In particular, experts recommend boric acid suppositories for some stubborn cases of recurrent vaginal candidiasis—an infection that doesn’t always respond to standard medication. A study from the Journal of Women’s Health found that over 70% of women with persistent yeast infections reported clear relief using boric acid capsules. Its value here grows from its steady action against difficult bacterial and fungal strains, all backed by clinical studies and doctor recommendations. Stringent quality standards matter at this point, since pharmaceutical-grade boric acid reduces impurities that could irritate delicate mucous membranes.
Plenty of liquid medicines need to last longer after the bottle is opened. Boric acid’s antifungal properties give many ear drops, topical solutions, and other multi-use medicinals a longer shelf life by slowing the growth of spoilage microbes. Take an ear infection treatment, for example—by keeping fungi and bacteria at bay, the treatment remains safe to use for longer periods. In my experience helping at a pharmacy in a humid region, we saw why this matters so much: temperatures above 30°C left products spoiled in days, unless a stable preservative like boric acid was included. Regulations set clear maximum limits, so these medicines stay effective but don’t risk patient safety.
During research or formulation development, boric acid acts as a buffering agent and a pH stabilizer in certain lab procedures and test kits. This isn't visible to most people, but it’s hard to develop a new drug without high-quality, reliable reagents. Pharmaceutical labs often favor BP/EP/USP grade boric acid since the rules around contaminants like heavy metals and other impurities are so strict. It means consistent research results and, ultimately, safer medications.
Though boric acid proves handy in so many pharmaceutical settings, questions sometimes come up about its safety with repeated or prolonged use, especially for infants and pregnant women. Research suggests boric acid has a low toxicity profile at recommended dosages, but healthcare providers stay careful by limiting exposure where possible. Product labeling, patient education, and clear protocols for storage and disposal help keep risks to a minimum. Where alternative preservatives or antifungals work just as well, pharmacists often switch—this safeguards public health without giving up the benefits boric acid offers where it is truly needed.
Boric acid keeps showing up on ingredient labels across everything from eye washes to foot powders. The grades labeled as BP, EP, and USP mean the product matches pharmaceutical standards set in Britain, Europe, and the United States. To understand if it belongs in skin creams or medicinal rinses, it’s smart to start with how this compound interacts with the body.
Regulatory agencies keep a close eye on safe limits. In cosmetics, the European Union only allows tiny amounts of boric acid due to concern over potential fertility risks and toxic effects. The US FDA classifies boric acid as "generally recognized as safe" for external use but draws a line at certain concentrations and routes, saying no to oral or large-scale topical use, especially on broken skin. It’s not surprising. Skin absorbs boric acid—slowly, but absorption increases with cuts or mucous membrane exposure.
Eye products tend to use very small doses, sticking to lower thresholds. Doctors still keep away from it in infant care, and even for adults, accidental swallowing or overuse has caused health problems in the past. The stories range from mild irritation to, rarely, serious poisoning. The reason for caution comes from boric acid's cumulative nature. The human body doesn't process boron all that quickly, so regular overexposure can build up trouble.
The rules around boric acid have tightened over time. Just a few decades ago, people used it liberally for diaper rash or as an all-purpose disinfectant. Reports of toxicity in infants forced a rethink. Doses that seemed fine in test tubes or for adults weren’t okay for babies, who soak up more through their skin and lack the kidney power to flush it out. Modern researchers keep noting that even for adults, the line between a useful preservative and an unwanted toxin proves pretty thin. Several cases of accidental poisoning have turned out fatal, especially among children.
People want products that last on the shelf but don’t cause side effects. Boric acid stands out for its ability to halt bacteria and fungi, which explains why it clings on as a preservative. At the same time, safer alternative preservatives have entered the scene. Brands covering babies and sensitive users have phased out boric acid almost entirely. In makeup, creams, and medicinal rinses for average consumers, it keeps a foothold through careful dose control and strict labeling.
The clearest way to avoid risk lies in following use instructions and noticing label warnings. Recognize that a little doesn’t always mean harmless, especially for those with compromised skin or chronic health issues. Swap out products or ask a healthcare provider for advice when in doubt, especially for young children or those prone to allergies. Producers can choose new preservatives where possible, stepping away from anything flagged by current research or regulatory guidance.
For anyone handling BP, EP, or USP grade boric acid themselves—maybe making DIY cosmetics—protective gloves and accurate measuring tools change the safety game. Public health authorities continue to update their advice in line with new studies. Staying informed keeps both consumers and makers on the safer side of innovation.
Boric acid, often talked about in older medicine cabinets and hospital supply rooms, carries a reputation for reliability in a clinical setting. The pharmaceutical grade version shows up on shelves with a responsibility to health and safety regulations. In daily work, companies usually offer it in tight, tamper-evident containers that limit contamination and protect people from exposure.
Most suppliers favor packaging sizes between 100 grams and 1 kilogram. Smaller bottles, such as 50 grams or 100 grams, offer enough material for clinics or busy laboratories without excess left open to air and moisture. Larger packaging like 500 grams or a kilogram serve research institutions or hospital pharmacies that need steady supply and less frequent restocking. Sometimes, I’ve seen even larger drums—up to 25 kilograms—reserved for compounding pharmacies or manufacturing, but these rarely show up in regular pharmacies.
Modern health care stresses precise dosing. Reselling boric acid in smaller, properly labeled containers allows for clear measurement. Larger containers hold a place in distribution, where a central team dispenses granular or powdered forms in controlled environments. Still, larger packages risk more air and moisture contact every time they're opened in daily use.
Smaller packages make sense for both safety and quality, cutting down on the chance of clumping and chemical breakdown. By using what’s needed and sealing the rest, clinics avoid unnecessary degradation. With stories in the news about tainted powders or misidentified chemicals, I reach for a fresh, sealed container every time. Not only do regulations demand this, but common sense calls for limiting cross-contamination or user error.
Shelf life for pharmaceutical grade boric acid usually runs around three to five years from the date of manufacture. This window depends on several key factors: how well the container seals, where the boric acid is stored, and the humidity of the environment. Medical professionals keep a close eye on expiration dates, because stability and purity figure into every clinical decision.
Left unchecked, boric acid pulls moisture from the air, which may cause it to clump or degrade faster than the labeled shelf life claims. If kept dry and away from direct sunlight, the chances of early spoilage drop. Pharmacy colleagues sometimes run monthly checks on inventory, rotating stock so nothing sits past its best-before date.
The main headache comes from improper storage: A cracked seal or leaky cap brings water, and the powder hardens or loses potency. Sometimes, it’s poor training, not deliberate negligence. If containers look beat up or caps lose their snap, there’s trouble. Switching to more robust, moisture-proof packaging could cut down on waste and risk.
Improved training for staff helps a lot. Clear date markers on every container keep everyone on the same page. For those working in smaller operations, building partnerships with trustworthy suppliers gives access to smaller sizes that fit actual needs, not just bulk orders.
Audits, ongoing education, and strong supplier relationships can push the standard higher, ensuring each dose stays safe and effective until the very last use. Pharmaceutical grade boric acid proves its worth not only through purity but also the hands and habits helping it reach patients safely.
Anyone who’s ever spent time in the pharmaceutical industry knows how quickly regulations shift. \Even so, some things don’t change—especially the big question everyone asks: does the product actually comply with pharmacopeia standards? I’ve spent more than a decade working with both generic and brand drug manufacturers. Every factory floor walks a tightrope between costs, speed, and the maze of global requirements. The word “compliance” doesn’t just echo in boardrooms; it fires up production teams, quality assurance, and the scientists who research product batches deep into the night.
Pharmacopeias—the sets of standards for identity, purity, and strength—aren’t a mere badge for marketing. If you stand in a US or European plant, inspectors reference United States Pharmacopeia (USP) or European Pharmacopoeia (Ph. Eur.) like gospel. Lapses in these set off alarms because they mean real risk for patients and real consequences for companies. It’s personal too—I recall a morning when a batch of medication failed because the raw material source changed, and the new supplier’s quality controls slipped just below Ph. Eur. requirements. We wasted weeks, lost trust, and the pressure from regulatory authorities didn’t let up for months.
Some companies believe once everything tests well for purity and identification, the job’s finished. The story goes much deeper. Take impurities. Many standards test for visible toxins, but the latest regulations reach deep into probable genotoxins and trace metals. These aren’t just regulatory buzzwords. Years ago, a tiny detection of nitrosamines set off a global recall. No one talks much about the number of analysts who had to sweat through revisiting the entire process—from raw materials to final packaging—scrambling under regulatory timelines.
The European Medicines Agency logged more than 1,000 recalls in a four-year period, most stemming from missed standards or documentation. On the US side, the FDA’s warning letters rarely forgive missing Certificates of Analysis or failing to stick to approved methods. This slicing detail explains why some manufacturers sink millions into equipment that automates every documented step. I’ve watched smaller firms try to thrift their way through testing, and those stories usually end with product holds, legal headaches, and worse, medicine shortages that hit clinics and pharmacies hard.
Patients lean on pharmacists and doctors, hoping what’s in the bottle matches the oversize promises on the label. They don’t see the regulatory filings or track the batch numbers, but confidence in any drug comes down to one thing: trust. Having sat in both boardroom reviews and frontline investigational teams, that trust is all you’re left with once an auditor starts peeling apart documentation. Compliance isn’t just a box on a checklist—each standard reflects decades of real harm, court cases, or patient suffering. People depend on us. Trust comes from vigilance, from hiring skilled analysts, from leadership that prioritizes long-term brand health over quarterly savings.
Digital batch recording cuts out costly errors. Regular in-house audits highlight the careless shortcuts that separate safe products from near-misses. Strong supplier relationships make sure every incoming shipment matches established specifications. I’ve seen the process from bench to bedside, and shortcuts in documentation or testing come back twice as hard. Staying on top of changes in pharmacopeia might not win company awards, but it keeps products on shelves and keeps the brand out of headlines—for all the right reasons.
I’ve handled boric acid in labs and watched folks in the industry overlook small storage details that end up costing them quality. Small mistakes don’t just lead to clumps or color changes—they can mess with analysis and set off alarms during audits.
Boric acid draws in water from air faster than you’d expect. Even in a bottle that feels tightly closed, excess moisture creeps in. Stored in humid places, boric acid forms lumps or cakes together. That ruins its powdery texture and impacts how much dissolves when the time comes to use it. If moisture reaches enough levels, you risk microbial growth. Unexpected bacteria or fungi in pharmaceutical or food batches? Nobody wants that liability.
High temperatures in storage rooms can push boric acid past what stability studies allow. Above 30°C, you’ll see more rapid changes—sometimes a different color, sometimes a gritty layer that feels off in your hands. Years ago, I watched a bin stored near a steamy pipe—it didn’t take long before nothing could salvage it. All those warning labels about storing in a “cool place” mean more than formal regulations—they’re learned lessons.
Some managers think skipping air-tight sealing saves money. In practice, wide-mouthed bins open to air lead to contaminated or substandard product. Dust, industrial fumes, and accidental splashes alter purity. In my experience, suppliers who use air-tight, chemical-resistant containers have fewer customer complaints and batch rejections, saving everyone time and money.
Chemical-resistant plastic or glass works best. Metal containers can react, especially if you ever see condensation. That tiny bit of interaction introduces impurities that ruin lab-grade boric acid.
Direct sunlight breaks down a lot of chemicals faster than you’d think. Boric acid isn’t the most photosensitive compound around, but storing it away from light slows degradation and avoids any subtle changes in quality. If you ever worked in warehouses with big glass panels or skylights, you see people shading shelves for good reason.
Cross-contamination builds up in shared storage rooms. A single spill or improper transfer touches off whole batch recalls. I saw a case where someone poured boric acid through a funnel meant for another chemical—the next QC check triggered an investigation. Color coding, dedicated scoops, and clean, labeled containers should be standard. Simple habits prevent expensive slipups.
Audit teams ask for more than a clean room and labeled boxes. They want logs—temperature checks, humidity records, batch rotations. As someone who’s watched regulatory auditors comb through these records, keeping detailed notes isn’t just bureaucracy; it proves your product’s journey stays safe from start to end. Using the oldest batch first (“first in, first out”) keeps nothing sitting too long and minimizes the risk of unnoticed deterioration.
Years of storing boric acid, both on the shelf and in bulk, drove home the point: habits matter. Set up climate control—dehumidifiers make a difference, especially during muggy seasons. Tighten up seals. Stick with dedicated storage areas. These choices don’t just follow industry rules—they let end users trust your product for everything from prescriptions to industrial solutions. A few smart changes can stop problems before they start.
| Names | |
| Preferred IUPAC name | trihydrooxidoboron |
| Other names |
Orthoboric Acid Boracic Acid Acidum Boricum Borofax Sassolite |
| Pronunciation | /ˈbɔːrɪk ˈæsɪd ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ɡreɪd/ |
| Identifiers | |
| CAS Number | 10043-35-3 |
| Beilstein Reference | \"3580076\ |
| ChEBI | CHEBI:33118 |
| ChEMBL | CHEMBL1406 |
| ChemSpider | 709 |
| DrugBank | DB00828 |
| ECHA InfoCard | 03bab74b-fff4-4181-b1c9-3b1c1d8bca65 |
| EC Number | 10043-35-3 |
| Gmelin Reference | 774 |
| KEGG | C01380 |
| MeSH | D001919 |
| PubChem CID | 5460 |
| RTECS number | **VZ1400000** |
| UNII | 3HSB44JRE |
| UN number | UN NOT REGULATED |
| CompTox Dashboard (EPA) | DTXSID2020787 |
| Properties | |
| Chemical formula | H3BO3 |
| Molar mass | 61.83 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.435 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -0.76 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 9.24 |
| Basicity (pKb) | 9.27 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.340 |
| Viscosity | Viscosity: 1.65 mPa·s (at 25 °C, for a 4% solution in water) |
| Dipole moment | 4.48 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 105.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −1094.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1094 kJ/mol |
| Pharmacology | |
| ATC code | S01AX03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May damage fertility or the unborn child. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H360FD: May damage fertility. May damage the unborn child. |
| Precautionary statements | Precautionary statements: Avoid contact with eyes, skin and clothing. Do not breathe dust. Wash thoroughly after handling. Use only with adequate ventilation. Keep container tightly closed. Store in a cool, dry place. Keep out of reach of children. |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 0, Instability: 0, Special: - |
| Autoignition temperature | 400°C |
| Lethal dose or concentration | LD50 (oral, rat): 2,660 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 2660 mg/kg |
| PEL (Permissible) | 10 mg/m3 |
| REL (Recommended) | 0.01 – 0.02% |
| Related compounds | |
| Related compounds |
Boric oxide Boron Borax Sodium borate Boron trioxide |
Chengguan District, Lanzhou, Gansu, China
